Search for: "Chilcott v. Chilcott"
Results 21 - 40
of 63
Sort by Relevance
|
Sort by Date
13 Dec 2011, 5:39 am
” Mayo v. [read post]
12 Dec 2011, 9:59 pm
Ireland Ltd. v. [read post]
12 Dec 2011, 1:28 pm
Warner Chilcott and Mayne Pharma International v. [read post]
19 Nov 2011, 10:06 pm
The answer is unclear because of the traditional insistence in English law that failure of consideration must be “total”, although there are signs (disputed by some) in recent years that this requirement is honoured more in its breach than in its observance (see for example the Privy Council in Goss v Chilcott, the Court of Appeal in Rover v Cannon [1989] 1 WLR 912 and the High Court in Giedo van der Garde v Force India Formula One Team). [read post]
2 Nov 2011, 2:00 am
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
26 Oct 2011, 2:30 am
Par files suit to stop government from expanding its reach (FDA Law Blog) US: Preparing for Mayo v. [read post]
7 Sep 2011, 4:22 am
: Pfizer v Teva (Property, intangible) [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Gemzar (Gemcitabine) – ALJ Rogers rules on motion to quash in Certain Gemcitabine (337-TA-766) (ITC Law Blog) Oestrin 24 Fe (Norethindrone acetate, Ethinyl estradiol) – US: Patent infringement complaint filed in response to Para IV certification: Warner Chilcott Co. v. [read post]
5 Apr 2011, 2:35 pm
District Court for the District of New Jersey in Medeva Pharma Suisse A.G. v. [read post]
29 Mar 2011, 9:19 pm
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU:… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
2 Feb 2011, 3:52 am
General Technical symposium to address access to medicines, patent information and freedom to operate (WIPO) Brazil: Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) India: Protection of Plant Varieties and Farmers’ Rights Authority appoints new Chairperson (Spicy IP) Italy: Tribunale di Milano: Mere filing of application for marketing authorization of a generic drug does not constitute infringing activity: Eli Lilly… [read post]
29 Dec 2010, 2:57 am
(Kluwer Patent Blog) US: BIO sends letter to DOJ on ‘clear and convincing evidence’ question raised in Microsoft v. i4i (Patent Docs) US: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
22 Dec 2010, 3:01 am
John’s patent research suit: St John’s University v Sanford M Bolton et al (Patent Docs) US: Affymetrix granted summary judgment for noninfingement of Illumina gene sequencing patents (Patent Docs) Products Actonel (Risedronate sodium) – US: Patent infringement complaint filed following a Paragraph IV certification: Warner Chilcott Co. [read post]
27 Oct 2010, 3:38 am
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
15 Sep 2010, 6:09 am
The manufacturers and marketers involved include Sanofi Aventis, Warner Chilcott, Roche, GlaxoSmithKline and Merck. [read post]
15 Jun 2010, 11:06 pm
The most high-profile in recent times has been the Chilcott Inquiry into the Iraq war, much of which was for the first time broadcast over the internet, therefore emphasising the role of public inquiries to subject controversial issues to public scrutiny. [read post]
22 Apr 2010, 3:51 am
(Patent Docs) Xibrom (Bromfenac) - US: District Court W D Tennessee: False marking complaint: Baker v Bausch & Lomb, Inc (Patent Docs) Zyprexa (Olanzapine) – Canada: Court denies Novopharm’s motion for Mareva injunction: Lilly v Novopharm (Pharmacapsules) [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW) General WHO documents from counterfeit meeting now… [read post]
11 Apr 2010, 9:36 pm
LLC et al. v. [read post]
